| 2025 | – | 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee |
| 2025 | – | Use of AI in Cardiac CT and MRI: A Scientific Statement from the ESCR, EuSoMII, NASCI, SCCT, SCMR, SIIM, and RSNA |
| 2025 | – | ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing |
| 2024 | – | 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery |
|
| 2024 | – | Joint CV Society Statement on HE/DEI |
| 2024 | – | 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy |
| 2024 | – | Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging |
| 2022 | – | SCMR/SNMMI/ACR/ASNC Joint Credentialing Statement for Cardiac PET/MRI |
| 2022 | – | SCMR/EACVI/ASE/SPR/NASCI Guidelines for the Use of CMR in Pediatric Congenital and Acquired Heart Disease |
| 2021 | – | AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain |
| 2021 | – | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging |
| 2021 | – | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization |
| 2020 | – | AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
